Mike Sergesketter
Analyst · Walthausen & Co. you may ask your question
Thanks, Don. During my comments, I will be referring to the slide deck Don mentioned, which can be found on our Investor Relations website within the Events and Presentations tab. Or if you’re listening via the webcast, you can follow along by advancing the slides on the webcast portal. As shown on Slide 3, our fourth quarter net sales were a new quarterly record of $318.6 million, which was a 15% increase compared to net sales of $276.8 million in the prior year fourth quarter. Adversely affecting our net sales for the quarter were foreign exchange rates, which reduced our net sales 3% during the fourth quarter a year ago. However, partially offsetting the impact of foreign currency rates were sales resulting from the GES acquisition, which added 2% to our consolidated net sales in the quarter. Slide 4 represents our net sales mix by vertical market. Three of our 4 end market verticals experienced double-digit growth over the prior year quarter. Our automotive vertical was up 12% compared to the same quarter a year ago as higher demand in North America, largely from new program introductions and, to a lesser extent, Europe, more than offset lower demand in China. Our medical vertical was up 16% in the current quarter compared to the prior year fourth quarter to a new quarterly record of over $100 million. The year-over-year increase was primarily related to strong demand for existing programs. Our industrial vertical was up 20% from a year ago as a result of additional revenue associated with the current year GES acquisition, new program introductions and an increase in demand for climate control products. Lastly, our public safety vertical was up slightly from the prior year fourth quarter. Our gross margin in the fourth quarter, reflected on Slide 5, was 7.3%, which declined from 8.2% in the fourth quarter of last fiscal year. Our decrease in gross margin in the current year quarter compared to a year ago included an adverse impact from GES on the lower-than-expected volumes as well as unfavorable mix and higher labor and benefit costs, which more than offset the leverage of increased volumes. Selling and administrative expenses, Slide 6 in the deck, were $13.1 million in the fourth quarter, which were up approximately $1.6 million in absolute dollars and relatively flat as a percentage of net sales compared to the prior year fourth quarter. The increase in selling and administrative absolute dollars was partly related to the amortization of finite live intangible assets, which were acquired with the GES acquisition. We also incurred higher warranty expense and technology-related costs during the quarter. Adjusted operating income for the fourth quarter, on Slide 7 in the deck, came in at $10.1 million or 3.2% of net sales. This compares to operating income of $11.3 million or 4.1% of net sales in the same period a year ago. The current quarter operating income was adjusted for $200,000 of income recognized related to proceeds received from class action lawsuits of which we were members. Other income and expense net was an expense of $1.6 million in this fourth quarter, which compares to an expense of $1 million in the fourth quarter of fiscal year 2018. Other expense net in the current year fourth quarter was primarily the result of $1.4 million of interest expense on increased borrowings on our credit facilities, including the financing of the GES acquisition and for general corporate purposes. Other expense net in the prior year fourth quarter was primarily the result of net foreign currency losses from unfavorable exchange rate fluctuations. The effective tax rate for the current year fourth quarter was approximately 14%. The current year quarter effective tax rate was favorably impacted by approximately $400,000 in both state tax credits and adjustments and federal R&D tax credit adjustments. In the prior year fourth quarter, the effective tax rate was an inflated 43%. The significantly higher prior year quarter rate was largely the result of adjustments related to the U.S. Tax Cuts and Jobs Act, or tax reform, as well as our higher fiscal year 2018 blended U.S. federal tax corporate rate of 28% and a valuation allowance recorded related to state tax credits. Slide 8 reflects our adjusted net income trend. Our GAAP net income in the fourth quarter of fiscal year 2019 came in at $7.5 million, and we had adjusted net income of $7.4 million after adjusting for the after-tax impact of proceeds received from the class action lawsuits. This compares to GAAP net income of $5.8 million and adjusted net income of $7.2 million in the fourth quarter of fiscal 2018. The non-GAAP adjusted net income of $7.2 million a year ago excluded adjustments related to tax reform. Diluted earnings per share ended up at $0.29 for the fourth quarter of this fiscal year, which is up from $0.22 of GAAP diluted EPS reported in the same quarter last year and $0.27 after adjusting for the impact from tax reform. Cash and cash equivalents at June 30, 2019, were $49.3 million. Operating cash flow trends are shown on Slide 11. Our cash flow provided by operating activities during the current year fourth quarter was $12.2 million as cash provided by net income plus non-cash items and a decrease in inventories more than offset a decrease in our accounts payable. Our cash flow provided by operating activities in the fourth quarter – in the prior year fourth quarter was $19.3 million. Our cash conversion days increased 14 days for the 3 months ended June 30, 2019, when compared to the same period in the prior year largely related to an increase in raw material inventories to maintain appropriate buffer stock levels in the current tight supply environment. Our cash conversion day calculation compared to the prior year quarter includes 15 days for contract asset days recognized as the result of the new revenue recognition guidance that we adopted during the first quarter of the current fiscal year, which was only partially offset by an 8-day reduction in our PDSOH, or production days sales on hand, our inventory metric. The contract asset days are a new metric this fiscal year and relate to the acceleration of revenue for work performed to date and recognized over time as we manufacture the product. The majority of our contracts and revenue are now recognized over time in accordance with the new revenue recognition guidance. The increase from the addition of the contract asset days should primarily be offset with the reduction in the PDSOH inventory days as inventory is relieved when revenue is recognized over time under the new revenue guidance. Also contributing to the increase in cash conversion days compared to the same period a year ago was a 5-day reduction in our accounts payable days and a 2-day increase in our DSO or days sales outstanding, receivables metric. Slide 12 reflects our capital and depreciation trends. Capital investments in the fourth quarter totaled $9.8 million largely related to manufacturing equipment to increase capacity and to support new production awards. Borrowings on our credit facilities at June 30, 2019, were $126 million, which were up from $8 million on June 30, 2018. The increase in borrowings during the current year is in large part related to funding the GES acquisition for working capital needs and for other domestic cash needs, including further repurchases of common stock our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, totaled $111 million at June 30, 2019. In conclusion, our financial condition is strong, and we are in excellent position to continue the solid growth trend while also driving hard to achieve our operating margin and return on invested capital goals. With that, I would like to open up today’s call to questions from analysts. Mel, do we have any analysts with questions in the queue?